日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

FLIPI24: A Modern Prognostic Model and Clinical Trial Enrichment Tool for Newly Diagnosed Follicular Lymphoma

FLIPI24:一种用于新诊断滤泡性淋巴瘤的现代预后模型和临床试验富集工具

Maurer, Matthew J; Prochazka, Vit K; El-Galaly, Tarec Christoffer; Flowers, Christopher R; Villa, Diego; Bachy, Emmanuel; Cahn, Elliot J; Fournier, Marguerite; Larson, Melissa C; Dietrich, Caroline E; Jakobsen, Lasse Hjort; Ghesquières, Hervé; Kridel, Robert; Gandhi, Maher K; Cheah, Chan Y; Hawkes, Eliza A; Seymour, John F; Freeman, Ciara L; Clausen, Michael R; Wahlin, Björn E; Friedberg, Jonathan W; Casulo, Carla; Habermann, Thomas M; Wang, Yucai; Nastoupil, Loretta J; de Nully Brown, Peter; Belada, David; Janíková, Andrea; Mocikova, Heidi; Fürst, Tomáš; Feugier, Pierre; Tilly, Hervé; Haioun, Corinne; Davies, Andrew J; Cartron, Guillaume; Burack, Richard; Chihara, Dai; Martin, Peter; Cohen, Jonathon B; Lossos, Izidore S; Kahl, Brad S; Sehn, Laurie H; Smedby, Karin E; Salles, Gilles; Trneny, Marek; Link, Brian K; Morschhauser, Franck; Cerhan, James R

ctDNA dynamics demonstrates rapid treatment response to tafasitamab + R-CHOP +/- lenalidomide and predicts outcome in diffuse large B-cell lymphoma: results from the phase 1b First-MIND study

ctDNA动态变化显示,tafasitamab + R-CHOP +/- 来那度胺治疗可快速改善弥漫性大B细胞淋巴瘤的预后:来自1b期First-MIND研究的结果

Khouja, Mouhamad; Kehden, Britta; Blair, Derek; Kuffer, Christian; Wagner, Steve; Versteegen, Tim; Nakov, Philipp; Brüggemann, Monika; Baldus, Claudia; Belada, David; Nowakowski, Grzegorz S; Schilhabel, Anke; Darzentas, Nikos; Pott, Christiane

Repression of miR-29 via MYC leads to increased CD40 signaling in transformed follicular lymphoma

MYC介导的miR-29抑制导致转化型滤泡性淋巴瘤中CD40信号增强

Filip, Daniel; Litzmanova, Katerina; Michaelou, Androniki; Kledus, Filip; Devan, Jan; Boudny, Miroslav; Hoferkova, Eva; Sharma, Sonali; Seda, Vaclav; Zeni, Pedro Faria; Borsky, Marek; Matulova, Kvetoslava; Kren, Leos; Oppelt, Jan; Blavet, Nicolas; Hejret, Vaclav; Urik, Milan; Mareckova, Andrea; Rimsza, Lisa M; Kamaradova, Katerina; Belada, David; Sykorova, Alice; Mocikova, Heidi; Trneny, Marek; Prouzova, Zuzana; Evans, Andrew G; Danilov, Alexey; Horn, Heike; Ott, German; Staber, Philipp; Mayer, Jiri; Friedberg, Jonathan W; Janikova, Andrea; Mraz, Marek

Correction: Brentuximab vedotin plus chemotherapy for the treatment of front-line systemic anaplastic large cell lymphoma: subgroup analysis of the ECHELON-2 study at 5 years' follow-up

更正:Brentuximab vedotin联合化疗一线治疗系统性间变性大细胞淋巴瘤:ECHELON-2研究5年随访亚组分析

Domingo-Domènech, Eva; Pro, Barbara; Illidge, Tim; Horwitz, Steven; Trumper, Lorenz; Iyer, Swami; Advani, Ranjana; Bartlett, Nancy L; Christensen, Jacob Haaber; Kim, Won-Seog; Feldman, Tatyana; Choi, Ilseung; Gritti, Giuseppe; Belada, David; Shustov, Andrei; Illes, Arpad; Zinzani, Pier Luigi; Hüttmann, Andreas; Trneny, Marek; Le Gouill, Steven; Jagadeesh, Deepa; Friedberg, Jonathan W; Little, Meredith; Dong, Cassie; Fanale, Michelle; Fenton, Keenan; Savage, Kerry J

Platelet-rich fibrin versus Gelfoam as external auditory canal packing in endoscopic tympanoplasty: a comparative clinical study

富血小板纤维蛋白与明胶海绵作为内镜鼓室成形术中外耳道填塞物的比较临床研究

Belada, Abdullah

Acalabrutinib Plus Bendamustine-Rituximab in Untreated Mantle Cell Lymphoma

Acalabrutinib 加苯达莫司汀-利妥昔单抗治疗未经治疗的套细胞淋巴瘤

Wang, Michael; Salek, David; Belada, David; Song, Yuqin; Jurczak, Wojciech; Kahl, Brad S; Paludo, Jonas; Chu, Michael P; Kryachok, Iryna; Fogliatto, Laura; Cheah, Chan Y; Morawska, Marta; Sancho, Juan-Manuel; Li, Yufu; Patti, Caterina; Forsyth, Cecily; Zhang, Jingyang; Lesley, Robin; Ramadan, Safaa; Rule, Simon; Dreyling, Martin

Epcoritamab plus GemOx in transplant-ineligible relapsed/refractory DLBCL: results from the EPCORE NHL-2 trial

Epcoritamab联合GemOx治疗不适合移植的复发/难治性弥漫性大B细胞淋巴瘤:EPCORE NHL-2试验结果

Brody, Joshua D; Jørgensen, Judit; Belada, David; Costello, Régis; Trněný, Marek; Vitolo, Umberto; Lewis, David John; Karimi, Yasmin H; Sureda, Anna; André, Marc; Wahlin, Björn E; Lugtenburg, Pieternella J; Jiang, Tony; Karagoz, Kubra; Steele, Andrew J; Abbas, Aqeel; Wang, Liwei; Risum, Malene; Cordoba, Raul

Fixed-duration epcoritamab plus R2 drives favorable outcomes in relapsed or refractory follicular lymphoma

固定疗程的依可利单抗联合R2方案可显著改善复发或难治性滤泡性淋巴瘤的疗效

Falchi, Lorenzo; Sureda, Anna; Leppä, Sirpa; Vermaat, Joost S P; Nijland, Marcel; Christensen, Jacob Haaber; de Vos, Sven; Holte, Harald; Merryman, Reid W; Lugtenburg, Pieternella J; Abrisqueta, Pau; Linton, Kim M; Sunkersett, Gauri; Hoehn, Daniela; Rana, Ali; Abbas, Aqeel; Marek, Jennifer; Hao, Yi; Steele, Andrew J; Morehouse, Christopher; Hutchings, Martin; Belada, David

Brentuximab vedotin plus chemotherapy for the treatment of front-line systemic anaplastic large cell lymphoma: subgroup analysis of the ECHELON-2 study at 5 years' follow-up

Brentuximab vedotin联合化疗一线治疗系统性间变性大细胞淋巴瘤:ECHELON-2研究5年随访亚组分析

Domingo-Domènech, Eva; Pro, Barbara; Illidge, Tim; Horwitz, Steven; Trumper, Lorenz; Iyer, Swami; Advani, Ranjana; Bartlett, Nancy L; Christensen, Jacob Haaber; Kim, Won-Seog; Feldman, Tatyana; Choi, Ilseung; Gritti, Giuseppe; Belada, David; Shustov, Andrei; Illes, Arpad; Zinzani, Pier Luigi; Hüttmann, Andreas; Trneny, Marek; Le Gouill, Steven; Jagadeesh, Deepa; Friedberg, Jonathan W; Little, Meredith; Dong, Cassie; Fanale, Michelle; Fenton, Keenan; Savage, Kerry J

Association of PET4 response with outcomes of BV-CHP vs CHOP in the ECHELON-2 trial in CD30+ peripheral T-cell lymphoma

ECHELON-2试验中,PET4反应与CD30+外周T细胞淋巴瘤患者BV-CHP方案与CHOP方案疗效的相关性

Iyer, Swaminathan; Mehta-Shah, Neha; Advani, Ranjana; Bartlett, Nancy L; Christensen, Jacob H; Morschhauser, Franck; Domingo-Domenech, Eva; Rossi, Giuseppe; Kim, Won Seog; Alpdogan, Onder; Feldman, Tatyana A; Camus, Vincent; Gritti, Giuseppe; Zinzani, Pier Luigi; Belada, David; Mayer, Jiri; Choi, Ilseung; Cheong, June-Won; Rustia, Evelyn; Fenton, Keenan; Fanale, Michelle; Savage, Kerry J; Horwitz, Steven M